We are live on
!
Find out more
M
Mirova Portfolio holdings
AUM
$2.46B
1-Year Est. Return
11.42%
This Fund
S&P 500
This Quarter
Est. Return
-10.42%
1 Year Est. Return
+11.42%
3 Year Est. Return
+32%
5 Year Est. Return
+23.08%
10 Year Est. Return
–
AUM
$219M
AUM Growth
–
Cap. Flow
+$230M
Cap. Flow
% of AUM
105.19%
Top 10 Holdings %
Top 10 Hldgs %
68.92%
Holding
95
New
95
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$36.4M |
| 2 |
Ecolab
ECL
|
+$27.8M |
| 3 |
Danaher
DHR
|
+$17M |
| 4 |
CGI
GIB
|
+$15.1M |
| 5 |
NVIDIA
NVDA
|
+$13.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.07% |
| 2 | Technology | 22.14% |
| 3 | Materials | 13.32% |
| 4 | Communication Services | 13.17% |
| 5 | Utilities | 7.58% |
Similar funds
BW
SCM
GWM
TW
JC
SG
RL
QT
Mirova's Q4 2018 Portfolio in Review
Q4 2018 is the first quarter with a 13F filing on record for Mirova, which disclosed 95 positions worth $219M. Its ten largest holdings account for 69% of the portfolio.
Its largest position is Thermo Fisher Scientific: 155,025 shares worth $34.7M.
By sector, the portfolio is most concentrated in Healthcare at 25% of assets, followed by Technology and Materials.
- Mirova's largest Q4 2018 buy was Thermo Fisher Scientific: 155,025 shares worth $34.7M.
- Mirova's ten largest holdings make up 69% of its $219M portfolio in Q4 2018.
- Mirova disclosed 95 positions in Q4 2018, its first 13F filing on record.
Based on Mirova's 13F filing for Q4 2018, filed 14 Feb 2019.